Literature DB >> 5301745

A suggestion for the prevention of severe clinical forms of schistosomiasis mansoni.

K Kloetzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5301745      PMCID： PMC2554355     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  3 in total

1.  SOME QUANTITATIVE ASPECTS OF DIAGNOSIS AND EPIDEMIOLOGY IN SCHISTOSOMIASIS MANSONI.

Authors:  K KLOETZEL
Journal:  Am J Trop Med Hyg       Date:  1963-05       Impact factor: 2.345

2.  [On the advantage of chemotherapy of schistosomiasis in a population in continuous contact with the foci. (Preliminary note)].

Authors:  K KLOETZEL
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1963 Mar-Apr       Impact factor: 1.846

3.  Splenomegaly in schistosomiasis mansoni.

Authors:  K KLOETZEL
Journal:  Am J Trop Med Hyg       Date:  1962-07       Impact factor: 2.345
  3 in total
  4 in total

1.  Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni.

Authors:  Amal M El-Shennawy; Amira H Mohamed; Mohamed Abass
Journal:  MedGenMed       Date:  2007-01-23

2.  Activity of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine against Schistosomiasis mansoni in mice.

Authors:  Sanaa Botros; Samia William; Olfat Hammam; Zdenĕk Zídek; Antonín Holý
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

3.  In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention.

Authors:  Tayo A Adekiya; Pradeep Kumar; Pierre P D Kondiah; Yahya E Choonara
Journal:  Pharmaceutics       Date:  2022-07-22       Impact factor: 6.525

4.  In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models.

Authors:  Tayo A Adekiya; Pradeep Kumar; Pierre P D Kondiah; Philemon Ubanako; Yahya E Choonara
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.